Clinical Trial: A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07035626) titled 'A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)' on June 08.

Brief Summary: This study is a single-center, double-blind, randomized controlled clinical trial with placebo as the control, aiming to evaluate the effectiveness of spermidine in preventing radiation-induced xerostomia during radiotherapy for head and neck tumors (including nasopharyngeal carcinoma).

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Radiation-induced Xerostomia

Intervention: DRUG: Spermidine

As a member of the p...